STOCK TITAN

Flyte Aviation (VTAK) SEC Filings

VTAK NYSE

Ticker history: VTAK became VJET (Flyte Aviation, Inc.) on .

Rhea-AI Summary

Flyte Aviation, Inc. (VJET) announced a multi-year partnership with the Philadelphia 76ers, naming Flyte the Official Private Aviation Partner. The companies expect to collaborate across digital and social media, premium hospitality, fan engagement, corporate partnerships and private aviation experiences.

Flyte will have opportunities to introduce its platform to 76ers fans, season-ticket members, premium customers and corporate partners while developing promotions and packaged experiences. The companies also plan to explore in-arena activations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Flyte Aviation, Inc. (VJET) reported record preliminary, unaudited third-quarter 2026 revenue of approximately $2.15 million, an increase of approximately 110% from $1.02 million in the second quarter. Aviation segment revenue rose 150% sequentially to approximately $1.87 million. MedTech revenue was approximately $280,000, up 24% year over year and 4% sequentially.

The preliminary results are subject to completion of the independent registered public accounting firm’s review and the company’s other financial reporting procedures; final results may differ. Its redesigned booking platform, launched in late May 2026, added more than 13,000 accounts, bringing the registered user base up 185% to more than 20,000. Direct-to-consumer revenue exceeded $500,000 in Q3.

Flyte said it has commenced Caribbean operations and is nearly finished with permitting to begin flying to and within Canada. It is in the process of adding aircraft, which it expects will support further revenue growth during the current quarter and into 2027. Flyte describes wholesale access to an established international network of private aviation professionals and their customers as complementary to its retail platform, which builds direct consumer relationships and technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Flyte Aviation, Inc. (VJET) said certain existing investors agreed to purchase 2,050 shares of Series C-4 Convertible Preferred Stock for aggregate gross proceeds of $2.05 million. Closing is expected on or about October 13, 2026, subject to customary closing conditions. At a $1.00 conversion price, holders may convert the preferred shares into up to 2,050,000 common shares, subject to a 4.99% beneficial ownership limit, which a holder may increase to up to 9.99% upon 61 days’ notice.

Flyte reduced the conversion price of outstanding Series C-1 through C-4 and Series D preferred stock from $2.30 to $1.00 per share and waived the applicable floor price as necessary. The Series J preferred conversion price was also reduced to $1.00; the related designation amendment had been approved by stockholders on September 30, 2026. The C-4 preferred shares and common shares issuable upon conversion are unregistered restricted securities, and additional Series J common shares resulting from the repricing are also unregistered. A 1-for-10 reverse stock split took effect October 5, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Catheter Precision, Inc., now Flyte Aviation, Inc., changed its name and effected a 1-for-10 reverse stock split effective October 5, 2026. Its common stock began trading on NYSE American as VJET, replacing VTAK, on a split-adjusted basis at the opening that day. Following the split, the company reported approximately 2,101,987 common shares issued and outstanding, subject to the cash-out of fractional shares.

Flyte says it plans fourth-quarter 2026 investments in an upgraded website, mobile application, digital marketing, AI data analytics and customer acquisition. It stated that its Life Sciences operations will not be capital constrained or downsized and that it is committed to continuing funding its ongoing research trials and studies. A cited third-party report estimates the 2026 U.S. private jet charter market at approximately $11.6 billion, with an estimated 6.9% annual growth rate, and says it could exceed $14 billion by 2029 and $16 billion by 2031. Flyte says it has not independently verified the market data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Catheter Precision, Inc. (VTAK) will change its name to Flyte Aviation, Inc. and effect a 1-for-10 reverse stock split at 12:01 a.m. Eastern Time on October 5, 2026. The company said issued and outstanding common shares will decrease from approximately 21,019,874 to approximately 2,101,987; authorized capital stock will remain 500 million common shares and 10 million preferred shares. Trading under the new name and VJET symbol is expected to begin at the October 5 opening.

Stockholders approved a 5,000,000-share increase to the 2023 Equity Incentive Plan reserve and a one-time repricing of options with exercise prices above fair market value to $0.152 per share. After the reverse split, the exercise price of each repriced option will be $1.52 per share; the repricing does not change option share counts, expiration dates or vesting schedules.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Catheter Precision, Inc. approved an amendment to change its name to Flyte Aviation, Inc. and effect a 1-for-10 reverse stock split, expected to become effective at 12:01 a.m. Eastern Time on October 5, 2026. Stockholders approved the split at a special meeting on April 15, 2026, and the Board selected the ratio within the approved range; the name change did not require stockholder approval.

The company intends to file a certificate of amendment. At the effective time, every ten shares issued and outstanding or held in treasury will be combined into one share. No fractional shares will be issued; holders otherwise entitled to a fraction will receive their pro rata portion of net proceeds from the exchange agent’s aggregation and sale of those shares. The split will not change the common stock’s par value or authorized share count, and outstanding equity awards, warrants, and convertible securities will be adjusted proportionately under their terms. Split-adjusted trading is expected to begin on the NYSE American under the name Flyte Aviation, Inc. and ticker VJET at the opening of trading on October 5, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
current report
Rhea-AI Summary

Catheter Precision, Inc. (VTAK) is asking stockholders at the September 30, 2026 virtual annual meeting to approve several governance and capital-structure changes, alongside routine items. One proposal would reincorporate the company from Delaware to Nevada via a plan of conversion, eliminating Delaware franchise taxes of approximately $200,000 per year and adopting Nevada articles and bylaws that include annual election of all directors and broader director/officer liability protections, while opting out of certain Nevada anti-takeover statutes.

Stockholders are asked to elect David A. Jenkins as the sole Class II director, authorize a discretionary reduction in the conversion price of 9,489.488 Series J preferred shares (held entirely by Mr. Jenkins and his affiliate) from $1.56 down to as low as $0.23 per share, and approve issuance of up to 340,000 common shares upon exercise of Series M warrants granted to Mr. Jenkins and FatBoy Capital, L.P. The Series J amendment could increase the Series J conversion from 6,083,005 to approximately 41,258,209 shares, or about 217% of the 18,972,049 shares outstanding as of the record date.

Additional proposals would increase the 2023 Equity Incentive Plan share reserve by 5,000,000 shares (to 5,067,888 available shares before evergreen adjustments), and authorize a one-time repricing of 507,764 outstanding stock options to fair market value on the approval date, affecting executives, directors and employees. Stockholders are also asked to ratify WithumSmith+Brown, PC as auditor for 2027 and to approve potential adjournment/postponement to solicit additional proxies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags
proxy
-
Rhea-AI Summary

Catheter Precision, Inc. (symbol: VTAK) is the issuer of record for a Form 424B3 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
prospectus
-
Rhea-AI Summary

Catheter Precision, Inc. (VTAK) is asking stockholders to approve seven items at the 2026 virtual annual meeting. Proposals include electing David A. Jenkins as the sole Class II director and reincorporating the company from Delaware to Nevada, eliminating the classified board so all directors stand for annual elections and reducing Delaware franchise tax costs (currently about $200,000 per year) in favor of Nevada’s lower fee regime.

Stockholders are also asked to approve a Series J preferred stock amendment allowing the board, subject to a floor, to cut the conversion price below $1.56, which could raise the maximum issuable common from Series J to about 41,258,209 shares versus 18,972,049 common shares outstanding as of August 18, 2026. Additional proposals cover authorizing up to 340,000 common shares upon exercise of Series M warrants, adding 5,000,000 shares to the 2023 Equity Incentive Plan, and a one-time repricing of 507,764 underwater options to fair market value (the stock last closed at $0.27 on August 18, 2026). A routine adjournment proposal and statutory dissenters’ rights in connection with the reincorporation are also described.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
proxy
Rhea-AI Summary

Catheter Precision, Inc. (VTAK) is reporting that a group of investment entities and individuals, including C/M Capital Master Fund, LP, WVP Emerging Manager Onshore Fund LLC, C/M Capital Partners, LP, Thomas Walsh and Jonathan Juchno, has filed a Schedule 13G regarding its position in the company’s common stock.

The Reporting Persons collectively report beneficial ownership of 1,597,328 shares of common stock, representing 9.99% of the outstanding class. This total includes 159,574 shares of common stock issuable upon conversion of convertible preferred stock held by the funds. Voting and dispositive power over these shares is reported on a shared basis among the group, while Messrs. Walsh and Juchno state that they disclaim beneficial ownership of shares held by the funds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
ownership

FAQ

How many Flyte Aviation (VTAK) SEC filings are available on StockTitan?

StockTitan tracks 64 SEC filings for Flyte Aviation (VTAK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Flyte Aviation (VTAK)?

The most recent SEC filing for Flyte Aviation (VTAK) was filed on October 14, 2026.